Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · July 10, 2024

Brigatinib in Patients With NF2-Related Schwannomatosis With Progressive Tumors

The New England Journal of Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

The New England Journal of Medicine
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
N. Engl. J. Med 2024 Jun 27;390(24)2284-2294, SR Plotkin, KH Yohay, PL Nghiemphu, CT Dinh, D Babovic-Vuksanovic, VL Merker, A Bakker, G Fell, L Trippa, JO Blakeley

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Brain Cancer Center of Excellence

Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.

Further Reading